HomeCompareBRMK vs CL

BRMK vs CL: Dividend Comparison 2026

BRMK yields 12.24% · CL yields 2.43%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BRMK wins by $1717140.29M in total portfolio value
10 years
BRMK
BRMK
● Live price
12.24%
Share price
$4.82
Annual div
$0.59
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1717140.34M
Annual income
$1,690,607,982,980.17
Full BRMK calculator →
CL
CL
● Live price
2.43%
Share price
$85.73
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.8K
Annual income
$5,401.96
Full CL calculator →

Portfolio growth — BRMK vs CL

📍 BRMK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBRMKCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BRMK + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BRMK pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BRMK
Annual income on $10K today (after 15% tax)
$1,040.46/yr
After 10yr DRIP, annual income (after tax)
$1,437,016,785,533.14/yr
CL
Annual income on $10K today (after 15% tax)
$206.23/yr
After 10yr DRIP, annual income (after tax)
$4,591.67/yr
At 15% tax rate, BRMK beats the other by $1,437,016,780,941.48/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BRMK + CL for your $10,000?

BRMK: 50%CL: 50%
100% CL50/50100% BRMK
Portfolio after 10yr
$858570.19M
Annual income
$845,303,994,191.07/yr
Blended yield
98.45%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

BRMK
Analyst Ratings
1
Buy
3
Hold
Consensus: Hold
Price Target
$6.13
+27.2% upside vs current
Range: $3.75 — $8.50
Altman Z
3.5
Piotroski
4/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+7.8% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BRMK buys
0
CL buys
0
No recent congressional trades found for BRMK or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBRMKCL
Forward yield12.24%2.43%
Annual dividend / share$0.59$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28.6%
Portfolio after 10y$1717140.34M$40.8K
Annual income after 10y$1,690,607,982,980.17$5,401.96
Total dividends collected$1715355.85M$18.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusHoldHold
Analyst price target$6.13$92.45

Year-by-year: BRMK vs CL ($10,000, DRIP)

YearBRMK PortfolioBRMK Income/yrCL PortfolioCL Income/yrGap
1← crossover$13,148$2,448.13$11,012$312.01+$2.1KBRMK
2$20,085$6,016.52$12,196$412.95+$7.9KBRMK
3$38,670$17,179.07$13,599$549.66+$25.1KBRMK
4$103,200$61,822.75$15,288$736.64+$87.9KBRMK
5$418,812$308,388.55$17,353$995.28+$401.5KBRMK
6$2,787,426$2,339,297.21$19,926$1,357.80+$2.77MBRMK
7$32,084,066$29,101,519.66$23,194$1,873.82+$32.06MBRMK
8$660,435,990$626,106,039.49$27,439$2,621.52+$660.41MBRMK
9$24,796,591,328$24,089,924,818.86$33,088$3,727.38+$24796.56MBRMK
10$1,717,140,335,701$1,690,607,982,980.17$40,806$5,401.96+$1717140.29MBRMK

BRMK vs CL: Complete Analysis 2026

BRMKStock

Broadmark Realty Capital Inc. operates as a commercial real estate finance company in the United States. It engages in underwriting, funding, servicing, and managing a portfolio of short-term trust loans to fund the construction and development, or investment in residential or commercial properties. The company has elected to be taxed as a real estate investment trust. As a result, it would not be subject to corporate income tax on that portion of its net income that is distributed to shareholders. The company was founded in 2010 and is headquartered in Seattle, Washington.

Full BRMK Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this BRMK vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BRMK vs SCHDBRMK vs JEPIBRMK vs OBRMK vs KOBRMK vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.